Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
- 1 January 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 36 (1) , 134-144
Abstract
Objective—: Pulmonary hypertension (PH) is characterized by progressive elevation of pulmonary vascular resistance, right ventricular failure, and ultimately death. We have shown that in rodents, hypoxia-induced mitogenic factor (HIMF; also known as FIZZ1 or resistin-like molecule-β) causes PH by initiating lung vascular inflammation. We hypothesized that hypoxia-inducible factor-1 (HIF-1) is a critical downstream signal mediator of HIMF during PH development. Approach and Results—: In this study, we compared the degree of HIMF-induced pulmonary vascular remodeling and PH development in wild-type (HIF-1α +/+ ) and HIF-1α heterozygous null (HIF-1α +/− ) mice. HIMF-induced PH was significantly diminished in HIF-1α +/− mice and was accompanied by a dysregulated vascular endothelial growth factor-A–vascular endothelial growth factor receptor 2 pathway. HIF-1α was critical for bone marrow–derived cell migration and vascular tube formation in response to HIMF. Furthermore, HIMF and its human homolog, resistin-like molecule-β, significantly increased interleukin (IL)-6 in macrophages and lung resident cells through a mechanism dependent on HIF-1α and, at least to some extent, on nuclear factor κB. Conclusions—: Our results suggest that HIF-1α is a critical downstream transcription factor for HIMF-induced pulmonary vascular remodeling and PH development. Importantly, both HIMF and human resistin-like molecule-β significantly increased IL-6 in lung resident cells and increased perivascular accumulation of IL-6–expressing macrophages in the lungs of mice. These data suggest that HIMF can induce HIF-1, vascular endothelial growth factor-A, and interleukin-6, which are critical mediators of both hypoxic inflammation and PH pathophysiology.Keywords
This publication has 61 references indexed in Scilit:
- RETRACTED: Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signalingProceedings of the National Academy of Sciences, 2012
- Digoxin inhibits development of hypoxic pulmonary hypertension in miceProceedings of the National Academy of Sciences, 2012
- Macrophages: Master Regulators of Inflammation and FibrosisSeminars in Liver Disease, 2010
- Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lungJournal of Experimental Medicine, 2009
- The effects of IL-6 on CD4 T cell responsesClinical Immunology, 2009
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1αNature, 2008
- Pulmonary arterial remodeling induced by a Th2 immune responseJournal of Experimental Medicine, 2008
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene familyThe EMBO Journal, 2000